TD Cowen analyst Stacy Ku raised the firm’s price target on KalVista (KALV) to $35 from $30 and keeps a Buy rating on the shares. The firm updated its model ahead of Q4 results.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KALV:
- KalVista’s Pediatric HAE Trial for Sebetralstat Reaches Completion, Setting Up a Key Catalyst for KALV
- KalVista price target raised to $37 from $27 at H.C. Wainwright
- KalVista price target raised to $29 from $28 at Citizens
- Strong Ekterly Launch and Latin America Expansion Underscore Buy Rating on KalVista
- KalVista Highlights Strong EKTERLY Launch and Global Uptake